HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease.

AbstractBackground:
Cyclophilin A (CyPA) is a secreted molecule that is regulated by inflammatory stimuli. Although inflammation has an important role in the pathogenesis of chronic obstructive pulmonary disease (COPD), little is known regarding the relationship between serum CyPA and COPD.
Methods:
Ninety-three COPD patients with acute exacerbation were enrolled in the study and were reassessed during the convalescence phase. Eighty-eight controls were matched for age, gender, body mass index, smoking index and comorbidity. The basic clinical information and pulmonary function of all participants were collected. Serum levels of CyPA and other inflammation indexes were further measured.
Results:
Serum CyPA was significantly increased in convalescent COPD patients compared to healthy controls, and further elevated in COPD patients with acute exacerbation. Serum CyPA positively correlated with serum interleukin-6, matrix metalloproteinase-9 and high-sensitivity C-reactive protein in both the exacerbation and convalescence phases of COPD. Furthermore, it negatively correlated with percent value of forced expiratory volume in 1 second (FEV1%) predicted and FEV1/forced vital capacity in convalescent COPD patients.
Conclusion:
These results suggest that serum CyPA can be used as a potential inflammatory biomarker for COPD and assessment of serum CyPA may reflect the severity of inflammation in COPD.
AuthorsMing Zhang, Jingjing Tang, Jiafeng Yin, Xiaoying Wang, Xiangli Feng, Xia Yang, Hu Shan, Qiuhong Zhang, Jie Zhang, Yali Li
JournalInternational journal of chronic obstructive pulmonary disease (Int J Chron Obstruct Pulmon Dis) Vol. 13 Pg. 357-363 ( 2018) ISSN: 1178-2005 [Electronic] New Zealand
PMID29403273 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • IL6 protein, human
  • Inflammation Mediators
  • Interleukin-6
  • C-Reactive Protein
  • MMP9 protein, human
  • Matrix Metalloproteinase 9
  • Cyclophilin A
Topics
  • Aged
  • Biomarkers (blood)
  • C-Reactive Protein (analysis)
  • Case-Control Studies
  • Convalescence
  • Cyclophilin A (blood)
  • Disease Progression
  • Female
  • Forced Expiratory Volume
  • Humans
  • Inflammation Mediators (blood)
  • Interleukin-6 (blood)
  • Lung (physiopathology)
  • Male
  • Matrix Metalloproteinase 9 (blood)
  • Middle Aged
  • Pulmonary Disease, Chronic Obstructive (blood, diagnosis, physiopathology, therapy)
  • Up-Regulation
  • Vital Capacity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: